Important Dates
Early Bird Registration :19th July 2026
Paper Submission Deadline :24th July 2026
Last Date of Registration : 3rd August 2026
Date of Conference : 18th - 19th August 2026
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
Track 01
Advancements in Alzheimer's Research
This track focuses on the latest findings in Alzheimer's disease research, emphasizing novel therapeutic approaches and interventions. Participants will explore cutting-edge studies that highlight the role of biomarkers in early diagnosis and treatment efficacy.
Track 02
Neurodegenerative Disease Mechanisms
This session will delve into the underlying biological mechanisms that contribute to neurodegenerative diseases. Discussions will include genetic, environmental, and lifestyle factors that influence disease progression.
Track 03
Biomarkers in Neurodegeneration
This track aims to present recent advancements in the identification and validation of biomarkers for neurodegenerative diseases. Researchers will share insights on how these biomarkers can enhance diagnostic accuracy and patient stratification.
Track 04
Neuroinflammation and Neurodegeneration
This session will explore the relationship between neuroinflammation and the progression of neurodegenerative disorders. Presentations will focus on the role of inflammatory pathways and potential therapeutic targets.
Track 05
Cognitive Decline and Biomarker Correlation
This track will investigate the correlation between cognitive decline and various neurodegenerative biomarkers. Researchers will present data on how these biomarkers can predict cognitive impairment and disease trajectory.
Track 06
Neuroimaging Techniques in Biomarker Discovery
This session will highlight the role of advanced neuroimaging techniques in the discovery and validation of neurodegenerative biomarkers. Participants will discuss the integration of imaging data with clinical outcomes.
Track 07
Translational Research in Neuroscience
This track will focus on the translation of basic neuroscience research into clinical applications for neurodegenerative diseases. Emphasis will be placed on collaborative efforts between researchers and clinicians.
Track 08
Psychosocial Factors in Neurodegenerative Diseases
This session will examine the psychosocial factors that influence the experience and management of neurodegenerative diseases. Discussions will include the impact of mental health on disease progression and patient outcomes.
Track 09
Innovative Therapeutics for Neurodegeneration
This track will showcase innovative therapeutic strategies being developed for the treatment of neurodegenerative diseases. Presentations will cover pharmacological and non-pharmacological interventions.
Track 10
Patient-Centered Approaches in Neuroscience
This session will focus on the importance of patient-centered approaches in the management of neurodegenerative diseases. Researchers will discuss strategies for involving patients in research and treatment decision-making.
Track 11
Future Directions in Neurodegenerative Biomarkers
This track will explore future directions and emerging trends in the field of neurodegenerative biomarkers. Participants will engage in discussions about the potential for personalized medicine and novel diagnostic tools.